Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a trial of LIB-01 for erectile dysfunction
NL-OMON59551Phase 2Completed
- Sponsor
- Dicot Pharma AB
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in erectile dysfunction (ED) comparing LIB-01 with Placebo (2 arms). Primary endpoints: Change from baseline in IIEF-EF domain score at week 4 and Safety. Started Nov 2024; status: completed.
02
Drugs
LIB-01
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NL-OMON59551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59551.